Bio-Techne Corp (TECH)
Current ratio
| Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | ||
|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 608,300 | 617,419 | 621,482 | 605,556 | 510,606 |
| Total current liabilities | US$ in thousands | 175,849 | 159,379 | 128,509 | 176,018 | 152,284 |
| Current ratio | 3.46 | 3.87 | 4.84 | 3.44 | 3.35 |
June 30, 2025 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $608,300K ÷ $175,849K
= 3.46
The current ratio of Bio-Techne Corp has exhibited fluctuations over the past several fiscal years. As of June 30, 2021, the company's current ratio stood at 3.35, indicating that current assets were approximately 3.35 times its current liabilities. This ratio increased modestly to 3.44 by June 30, 2022, reflecting a slight improvement in the company's short-term liquidity position. A more significant increase was observed by June 30, 2023, when the current ratio rose to 4.84, suggesting a notable strengthening of the company's ability to cover its current liabilities with current assets.
However, the ratio declined somewhat in subsequent years, descending to 3.87 as of June 30, 2024, and then further decreasing to 3.46 on June 30, 2025. Despite this decline, the value remained robust, indicating that Bio-Techne continued to maintain a healthy liquidity cushion relative to its current obligations.
Overall, the company's current ratio has remained well above the generally acceptable threshold of 1.0, demonstrating a consistent capacity to meet short-term liabilities. The transient peaks and troughs over this period reflect normal operational and financial management adjustments but do not suggest any imminent liquidity concerns.
Peer comparison
Jun 30, 2025